Search Results 341-350 of 17814 for Coagulate

1. Phase 1/2 Study of AG-221 in Subjects With Advanced Hematologic Malignancies With an IDH2 Mutation - Mayo Clinic

   ... coagulation. In the Phase 2 portion of the trial only, subjects who have previously received treatment with an inhibitor of Isocitrate dehydrogenase protein ...

2. A Study of Response, Survival, Safety, and Tolerability of Lenvatinib for the Treatment of Anaplastic Thyroid Cancer - Mayo Clinic

   Adequate blood coagulation function as evidenced by an International Normalized Ratio (INR) ≤ 1.5; Adequate liver function. Bilirubin ≤ 1.5 x upper limit of ...

3. Temozolomide and Irinotecan Hydrochloride with or without Bevacizumab in Treating Young Patients with Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors - Mayo Clinic

   Adequate coagulation defined as. International normalized ratio (INR)/prothrombin time (PT) ≤ 1.5 x upper limit of normal. Exclusion Criteria: Patients with ...

4. Innovations in blood and blood products for adult trauma patients - Mayo Clinic

   Journal of Trauma and Acute Care Surgery. 2009;66:S69. Jobes D, et al. Toward a definition of "fresh" whole blood: An in vitro characterization of coagulation ...

5. Study of INBRX-109 in Conventional Chondrosarcoma - Mayo Clinic

   Adequate hematologic, coagulation, hepatic and renal function as defined per protocol. 5. Eastern Cooperative Oncology Group performance status (ECOG PS) of ...

6. Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer - Mayo Clinic

   Have adequate coagulation functioning within 15 days prior to start of study treatment, defined by either of the following criteria: INR < 1.5 × ULN; OR for ...

7. https://www.mayoclinic.org/spanish_patient_consumer_faq.xml

8. Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   ... coagulation including von Willebrand's Disease); Severely impaired lung function as defined as spirometry and DLCO that is 50% of the normal predicted value ...

9. A Study of Donated Alloantigen Reactive Regulatory T Cells for Reducing or Discontinuing Immune System Suppression in Liver Transplant Patients - Mayo Clinic

   Any chronic condition for which anti-coagulation cannot be safely interrupted for liver biopsy; Positive pregnancy test; Peripheral blood Tregs <30/μL at ...

10. A Study to Assess the Feasibility of Combining Clinically- indicated MitraClip Transcatheter Mitral Valve Repair (TMVR) and Watchman Left Atrial Appendage Occlusion (LAAO)

    Family history of VTE or of inherited prothrombotic disorder, recurrence/extension of thrombosis while adequately anti-coagulated. The patient is actively ...